• Palmitic acid: Protocol and QC Guide

  2026-08-20

  Palmitic acid (hexadecanoic acid, SKU N2456) provides a defined saturated long-chain fatty acid for lipid metabolism, insulin signaling, inflammation, and protein palmitoylation workflows. It is unsuitable for aqueous stock preparation and long-term solution storage, so solvent selection, matched vehicle controls, and prompt use are central to reproducible assays.

• SGI-1027 and Everolimus in Renal Cancer

  2026-08-20

  A 2024 Advanced Science study identifies SGI-1027 as an inducer of vacuolation and methuosis in renal cancer cells and shows that it cooperates with everolimus to suppress malignant phenotypes. The combination links lysosomal membrane permeability to apoptosis and GSDME-dependent pyroptosis, offering a mechanistic strategy for investigating everolimus resistance.

• Carboplatin in 3D Ovarian Cancer Models

  2026-08-19

  Carboplatin is a platinum-based DNA synthesis inhibitor whose activity can change substantially between 2D monolayers and 3D tumor models. This evidence-focused guide connects proteomic model selection with practical assay design for preclinical oncology research.

• Anlotinib Hydrochloride in Angiogenesis Assays

  2026-08-19

  Build mechanism-aware angiogenesis workflows around Anlotinib hydrochloride, from endothelial migration and tube formation to receptor and ERK pathway validation. This guide connects quantitative assay design with a translational cancer case while emphasizing controls, optimization, and research-use limitations.

• Sulfo-NHS-LC-Biotin: Practical Labeling Guide

  2026-08-18

  Sulfo-NHS-LC-Biotin is a water-soluble reagent for covalent biotin labeling of accessible primary amines on proteins, peptides, and intact-cell surfaces. It is suited to irreversible extracellular labeling and streptavidin-based capture, but not to intracellular or reversible biotinylation workflows.

• Puerarin Activates NO Signaling in Dental Follicle Cells

  2026-08-18

  The reference study shows that puerarin enhances the osteogenic differentiation of rat dental follicle cells and links this effect to nitric oxide, cyclic GMP, soluble guanylate cyclase, and PKG-1 signaling. Its inhibitor-based design provides a useful framework for testing nitric oxide pathway modulation during periodontal regeneration research, while also highlighting limitations in cell-model and pathway specificity.

• FAISL, FAK Proteolysis, and TNBC Metastasis

  2026-08-17

  The 2024 Advanced Science study identifies FAISL as a long noncoding RNA that stabilizes focal adhesion kinase by blocking Calpain 2-mediated proteolysis. Its findings connect lncRNA-dependent control of FAK protein turnover with triple-negative breast cancer adhesion, survival, progression, and metastasis, while providing a rationale for FAISL-targeted RNA delivery.

• Apigenin Workflows for Oncology and Neuroprotection

  2026-08-17

  Apigenin supports parallel oncology and neuroprotection workflows by combining HDAC-linked apoptosis studies with ROS, DNA-damage, mitochondrial, and inflammation readouts. This practical guide covers dosing, assay design, cross-model interpretation, and troubleshooting for more reproducible preclinical experiments.

• Spermine: Designing Causal Ion Channel Assays

  2026-08-16

  Spermine is an endogenous polyamine whose voltage-dependent control of IRK1 channels makes it valuable for disciplined ion channel regulation studies. This evidence-calibrated guide connects channel assays with emerging herpesvirus nuclear egress research while separating established mechanisms from testable hypotheses.

• Rottlerin: A PKC Probe for Entry Biology

  2026-08-15

  Rottlerin is a PKC inhibitor with applications extending from apoptosis and cell proliferation to mechanistic studies of pathogen entry. This article develops an assay-centered framework connecting Rottlerin pharmacology with Spiroplasma eriocheiris uptake in Drosophila S2 cells while emphasizing controls, interpretation, and cross-domain limitations.

• Losmapimod: From p38 Binding to Assay Design

  2026-08-14

  Losmapimod and GW856553X offer a precise way to interrogate p38α/β signaling. This article translates structural evidence on kinase–phosphatase coupling into better assay controls for inflammation, vascular function, hypertension, and COPD research.

• Calpain Inhibitor II, ALLM: A Protease Assay Framework

  2026-08-14

  Calpain Inhibitor II, ALLM is a cell-permeable cysteine-protease inhibitor with value beyond simple apoptosis induction. This guide explains how to interpret its target profile, connect calpain-2-dependent FAK proteolysis to assay design, and avoid overclaiming selectivity in cancer models.

• Doxorubicin Hydrochloride Research Workflows

  2026-08-13

  Doxorubicin hydrochloride supports both cancer-cell mechanism studies and carefully controlled cardiotoxicity models, making it more than a simple viability reagent. This workflow shows how to connect dose response, apoptosis, metabolic stress, and cardiac safety readouts while avoiding common handling and interpretation errors.

• CCL7+ Macrophages and CRC Immunotherapy Resistance

  2026-08-13

  The reference study identifies CCL7+ tumor-associated macrophages as a mechanistic driver of immune checkpoint inhibitor resistance in colorectal cancer. Its findings connect macrophage metabolism, CXCL10-dependent CD8+ T-cell recruitment, and anti-PD-L1 response, providing a rationale for testing macrophage-centered combination strategies.

• Pancreatic Ductal Organoids: A Small-Molecule Protocol

  2026-08-12

  Liao and colleagues developed a small-molecule culture strategy that improves the initiation and long-term expansion of pancreatic ductal organoids while retaining ductal and acinar populations. The approach provides a more efficient platform for pancreatic disease modeling, cellular plasticity studies, and future high-throughput drug screening.

16426 records 1/1096 page Next 12345 下5页 Last page